| Sex-specific thresholds of high-sensitivity troponin in patients with suspected acute coronary syndrome KK Lee, AV Ferry, A Anand, FE Strachan, AR Chapman, DM Kimenai, ... Journal of the American College of Cardiology 74 (16), 2032-2043, 2019 | 120 | 2019 |
| High-sensitivity cardiac troponin on presentation to rule out myocardial infarction: a stepped-wedge cluster randomized controlled trial A Anand, KK Lee, AR Chapman, AV Ferry, PD Adamson, FE Strachan, ... Circulation 143 (23), 2214-2224, 2021 | 116 | 2021 |
| Direct comparison of clinical decision limits for cardiac troponin T and I DM Kimenai, RMA Henry, CJH van der Kallen, PC Dagnelie, MT Schram, ... Heart 102 (8), 610-616, 2016 | 81 | 2016 |
| Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction J Hung, A Roos, E Kadesjö, DA McAllister, DM Kimenai, ASV Shah, ... European heart journal 42 (26), 2552-2561, 2021 | 68 | 2021 |
| Sex-specific versus overall clinical decision limits for cardiac troponin I and T for the diagnosis of acute myocardial infarction: a systematic review DM Kimenai, EBNJ Janssen, KM Eggers, B Lindahl, HM den Ruijter, ... Clinical chemistry 64 (7), 1034-1043, 2018 | 68 | 2018 |
| Origin of cardiac troponin T elevations in chronic kidney disease N van der Linden, T Cornelis, DM Kimenai, LJJ Klinkenberg, JM Hilderink, ... Circulation 136 (11), 1073-1075, 2017 | 61 | 2017 |
| Risk factors for type 1 and type 2 myocardial infarction R Wereski, DM Kimenai, A Bularga, C Taggart, DJ Lowe, NL Mills, ... European heart journal 43 (2), 127-135, 2022 | 55 | 2022 |
| Cardiac troponin thresholds and kinetics to differentiate myocardial injury and myocardial infarction R Wereski, DM Kimenai, C Taggart, D Doudesis, KK Lee, MTH Lowry, ... Circulation 144 (7), 528-538, 2021 | 54 | 2021 |
| Twenty-four-hour biological variation profiles of cardiac troponin I in individuals with or without chronic kidney disease N Van Der Linden, JM Hilderink, T Cornelis, DM Kimenai, ... Clinical Chemistry 63 (10), 1655-1656, 2017 | 47 | 2017 |
| Reference ranges for NT-proBNP (N-terminal pro-B-type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort P Welsh, RT Campbell, L Mooney, DM Kimenai, C Hayward, A Campbell, ... Circulation: Heart Failure 15 (10), e009427, 2022 | 37 | 2022 |
| Strong diurnal rhythm of troponin T, but not troponin I, in a patient with renal dysfunction N van der Linden, T Cornelis, LJJ Klinkenberg, DM Kimenai, JM Hilderink, ... Int J Cardiol 221 (287), 8, 2016 | 37 | 2016 |
| Socioeconomic deprivation: an important, largely unrecognized risk factor in primary prevention of cardiovascular disease DM Kimenai, L Pirondini, J Gregson, D Prieto, SJ Pocock, P Perel, ... Circulation 146 (3), 240-248, 2022 | 36 | 2022 |
| Biological variation of creatinine, cystatin C, and eGFR over 24 hours JM Hilderink, N van der Linden, DM Kimenai, EJR Litjens, ... Clinical chemistry 64 (5), 851-860, 2018 | 36 | 2018 |
| Sex differences in cardiac troponin I and T and the prediction of cardiovascular events in the general population DM Kimenai, ASV Shah, DA McAllister, KK Lee, A Tsanas, SJR Meex, ... Clinical chemistry 67 (10), 1351-1360, 2021 | 35 | 2021 |
| Stress-Axis Regulation by Vitamin D3 in Multiple Sclerosis L Rolf, J Damoiseaux, I Huitinga, D Kimenai, J Van den Ouweland, ... Frontiers in neurology 9, 263, 2018 | 28 | 2018 |
| Role of sFlt-1 and PlGF in the screening of small-for-gestational age neonates during pregnancy: a systematic review MLE Hendrix, JAP Bons, A Van Haren, SMJ van Kuijk, W van Doorn, ... Annals of Clinical Biochemistry 57 (1), 44-58, 2020 | 27 | 2020 |
| Sex-related aspects of biomarkers in cardiac disease AMA Mingels, DM Kimenai Sex-Specific Analysis of Cardiovascular Function, 545-564, 2018 | 27 | 2018 |
| Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort P Welsh, DM Kimenai, RE Marioni, C Hayward, A Campbell, D Porteous, ... Clinical Chemistry and Laboratory Medicine (CCLM) 60 (11), 1820-1829, 2022 | 26 | 2022 |
| Vitamin K antagonists, non–vitamin K antagonist oral anticoagulants, and vascular calcification in patients with atrial fibrillation FECM Peeters, EAMP Dudink, DM Kimenai, B Weijs, S Altintas, ... TH Open 2 (04), e391-e398, 2018 | 26 | 2018 |
| Estimated glomerular filtration rate and albuminuria are associated with biomarkers of cardiac injury in a population-based cohort study: the Maastricht study RJH Martens, DM Kimenai, JP Kooman, CDA Stehouwer, FES Tan, ... Clinical Chemistry 63 (4), 887-897, 2017 | 25 | 2017 |
